The global intravenous catheters market size is estimated to reach USD 13.07 billion by 2030, registering a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising R&D investments for risk free IV catheter products, increasing demand for disposable IV catheters, and increasing demand for antimicrobial IV catheters are the major driving factors accelerating the industry growth. Novel product launch, increasing mergers and acquisition among the industry key players, and the rising demand for specialized IV catheters for specific patient population based on age group are key contributors to the market growth.
The industry key players are involved in manufacturing novel IV catheter devices which also enhance the product portfolio. Launching new products is essential for transforming the market, offering novel strategies, and addressing unmet needs in patient care. With the goal of improving patient outcomes and streamlining healthcare procedures, these innovative products frequently combine cutting-edge technologies, increased safety measures, and enhanced functionality.
In November 2023, BD launched new needle-free blood collection equipment that is suitable with integrated catheters. The U.S. FDA has granted the PIVO (Peripherally Inserted Vascular Output device) Needle-Free Blood Collection device received 510(k) approval. The design developments of the devices enable it to be the first and only needle-free blood collection device that is compatible with both integrated and long peripheral intravenous catheters, such as the NexivaTM closed intravenous catheter system with NearPortTM intravenous access. This enhances the PIVO functionality that has been provided since 2017 with conventional short peripheral IV catheters.
Request a free sample copy or view report summary: Intravenous Catheters Market Report
Based on type, peripheral catheters segment dominated the market in 2024 with a share of 41.1% owing to the cost-effectiveness, ease of insertion and low risk of complications
The hospital pharmacies segment held the largest revenue share in 2024. The increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for intravenous catheters in the near future
North America dominated the regional market with the highest revenue share of 34.8% in 2024 owing to high incidence rate of neurological disease, infections, and urological diseases in this region.
Grand View Research has segmented the global intravenous catheters market based on type, end-use, and region:
Intravenous Catheters Type Outlook (Revenue, USD Million, 2018 - 2030)
Peripheral Catheters
Midline Peripheral Catheters
Central Venous Catheters
Intravenous Catheters End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital Pharmacies
Retail Pharmacies
Others
Intravenous Catheters Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Intravenous Catheters Market
Mediplus India Ltd
Sterimed Group
Medilivescare Manufacturing Pvt. Ltd.
Angiplast Pvt Ltd.
Medtronic
Boston Scientific Corporation
Teleflex Incorporated
B. Braun SE
BD
Terumo Medical Corporation
Nipro Europe Group Companies
"The quality of research they have done for us has been excellent..."